Quanticate, a global data-focused clinical research organisation (CRO), is further expanding its service offering into India with the opening of a new office.
Strategically located in Bangalore, with access to the country’s extensive talent pool in the pharmaceutical services industry, the new office will be a base from which Quanticate will broaden its capabilities for the management, analysis and reporting of data from clinical trials and post-marketing surveillance.
The decision to open the office follows a very successful year for Quanticate which saw an increase in sales driving the demand for more resources both in India and further afield. The new 16,500sqft premises doubles the company’s current footprint in the country.
Praveen Dass, VP of clinical data management and head of Indian operations at Quanticate explains: “By expanding our presence in India, we are able to increase our capacity meaning we can cater for more clients on a larger scale.“We have an ambitious growth strategy to deliver over the next five years, which aims to employ over 60 new members of staff in the coming months. Our new office provides the perfect platform for this growth and marks an important milestone in our journey.”
As the company’s new operational center of excellence, the facility will also help Quanticate to provide outstanding customer service for its global client base and support further development of collaborative, long-term partnerships with leading pharmaceutical companies.
The CROs increased presence in the region has recently allowed Quanticate to engage with a diverse range of industry-specific groups, including the Society for Clinical Data Management (SCDM) India and Pharmaceutical Users Software Exchange (PhUSE) India. The company has representatives on the steering committee and co-chaired the first Society for Clinical Data Management (SCDM) Single Day Event (SDE).
Quanticate is a data-focused CRO which specialises in the management, analysis and reporting of data from clinical trials and post-marketing surveillance. Its team of experts supports a global portfolio of clients across areas such as biostatistics, statistical programming, clinical data management, statistical monitoring, medical writing and pharmacovigilance.
For more information about Quanticate visit http://www.quanticate.com/clinical-biostatistics-services.
Quanticate is a leading global data focused clinical research organisation (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. As experts in clinical data, Quanticate provides high quality teams that offer efficient outsourcing solutions for biostatistics, SAS programming, clinical data management, statistical monitoring, medical writing and pharmacovigilance. Quanticate can offer study level support, functional service provision (FSP), strategic full data-services solutions or technical consultancy to meet the needs of pharmaceutical, biotechnology and device companies across the globe. By offering high quality, value-add client specific solutions to meet current and future development needs, Quanticate has become the supplier of choice for many companies from top tier pharmaceutical giants through to niche biotechnology and device companies. Please visit the website at www.quanticate.com for further information and access to white papers.